Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Clinical Utility of the MDS Test for the Oncogenic Activity in Nevi Suspected of Being Melanoma

NCT03109327 is registered in ClinicalTrials.gov with Orlucent, Inc as lead sponsor.

NCT NCT03109327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Clinical Utility of the MDS Test for the Oncogenic Activity in Nevi Suspected of Being Melanoma
Lead sponsor
Orlucent, Inc
Phase
Observational
Overall status
Completed
Start date
April 1, 2018
Completion date
October 30, 2020
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, moles, skin lesion